A few examples are:
Sahil Diwan, the co-founder and CEO of SafKan Health, the winner of SAC XI, a medtech company based in Seattle with a mission to bring ear care into the 21st century, have raised capital, run successful clinical trials, secured two patents, received FDA 510(k) clearance, and brought a new medical innovation to market.
Alertive Health Care a SAC XIII co-winner just was acquired by Carbon Health. https://www.businesswire.com/news/home/20211005005679/en/Carbon-Health-Acquires-Remote-Patient-Monitoring-Company-Alertive-Healthcare-to-Expand-Omnichannel-Care-Delivery
Elliot Fisher shared how Curi bio, SAC XIII co-winner pivoted to platform methodology thereby accelerating the discovery of the next generation of medicines by integrating human cells, systems, and data and receiving a $6Million Series A.
Abterra Biosciences (who won as Digital Proteomics) was the SAC 19 winner. In 2021 they graduated from the Johnson & Johnson Incubator JLABs and moved to a bigger lab at the San Diego Science Center, significantly increasing capabilities. The team doubled in size. They sequenced their 5,000th hybridoma; worked on antibody discovery and antibody protein sequencing projects, and doubling 2020 capacity. A new mass spectrometer, an Orbitrap Eclipse Tribrid will translate to shorter project timelines, and enable the launch of some exciting new technologies.